Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis
Year: 2019
Type: article
Study design: Observational Study
Source: Journal of Cystic Fibrosis
Authors: Amy Coward, Dervla T.D. Kenna, Neil Woodford, Jane F. Turton, Malcolm Armstrong, Cressida Auckland, Ian Bowler, Phillipa Burns, James Cargill, Mary Carroll, William Flight, Michelle Graver, Heather Green, Carolyne Horner, Andrew Jones, Andrew M. Jones, Graeme Jones, Sarah Mayell, Jeorge Orendi, Audrey Perry, Ali Robb, Natasha Tucker, David Waine, Trevor Winstanley, Nick Withers
Institutions: Public Health England, Manchester University NHS Foundation Trust, Royal Manchester Children's Hospital, Royal Devon & Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital, John Radcliffe Hospital, Alder Hey Children's NHS Foundation Trust, Alder Hey Children's Hospital, University Hospital Southampton NHS Foundation Trust, King's College Hospital NHS Foundation Trust, King's College Hospital, Wythenshawe Hospital, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Royal Brompton & Harefield NHS Foundation Trust, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, Freeman Hospital, Plymouth Hospital, University Hospitals Plymouth NHS Trust, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Broomfield Hospital
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Roche, Johns Hopkins University, Bio-Rad Laboratories, Melinta Therapeutics, Momentum Bioscience, National Institute for Health and Care Research, Department of Health and Social Care, British Society for Antimicrobial Chemotherapy, Food Standards Agency, Public Health England, Department of Health and Aged Care, Australian Government, Meiji Seika Pharma, Basilea Pharmaceutica, bioMérieux, Merck Sharp and Dohme
OpenAlex ID: W2996554162